Medicxi launches €267m fundNovartis and Alphabet/Google asset Verily Life Sciences LLC has co-invested into the late stage fund designed to finance programmes with up to €25m post clinical proof of concept. more ➔
Germany is blocking EU Unitary Patent CourtGermany’s Constitutional Court has stopped the government from ratifying the EU’s Unitary Patent Package. At the time of the announcement, The German Bundestag and Council of Federal states had already … more ➔
Abivax Ebola antiviral gets financing French virology company Abivac will receive €390,000 for the development of a polyclonal antibody cocktail to fight Ebola. more ➔
Centogene raises a €25m in Series A financingOrphan diseases diagnostics specialist Centogene AG said it will use the funds for biomarker and CDx development based on its proprietary CentoMD mutation database. more ➔
Bonesupport is planning €60m IPO Swedish orthobiologics company Bonesupport Holding AB announced on Sunday it will go public at Nasdaq Stockholm. more ➔
Targovax raises €21m in private placementNorwegian cancer med developer Targovax ASA has doubled its cash and cash equivalents as of 31 December 2016 by raising NOK200m (€21m) in a private placement of new shares. more ➔
Grünenthal in US$300m deal with AstraZenecaGerman Grünenthal Group has entered into an agreement to acquire the global rights to AstraZeneca’s migraine treatment Zolmitriptan. more ➔
Biocartis launches partnership in liquid biopsyBelgian liquid biopsy specialist Biocartis Group NV has announced it will co-develop a breast cancer assay with MRC Technology. more ➔
Merck KGaA and F-star in €1bn dealGerman Merck KGaA has secured an option on UK’s F-Star Biotechnology Ltd’s preclinical bispecific PD-L1/LAG checkpoint inhibitor FS118 and four candidates in discovery stage. more ➔
Bicycle raises £40mCambridge-based cancer company Bicycle Therapeutics has raised £40m to advance its clinical pipeline of peptide-based conjugates with antibody-like binding properties. more ➔
